A

Alexion

Global biopharmaceuticals focusing on rare diseases

Associate Director Regional Market Access

Business OperationsConfirmed live in the last 24 hours
Full-timeMunich, GermanyNo salary listed

About the Job

Requirements

  • A Master’s or advanced degree in Health Economics, pharmacy, public health, or another relevant field for Market Access.
  • At least 2 years of relevant experience in the pharmaceutical or biotechnology industry in similar positions; experience launching products in new therapeutic areas is preferable.
  • In-depth knowledge of the German health care system.
  • Excellent knowledge of the hospital and outpatient care funding system in Germany.
  • An established strong network of relevant experts and stakeholders.
  • Demonstrated ability to implement access strategies for commercialized and pre-launch products and market preparation.
  • Ability to understand and clearly communicate scientific and pharmaceutical information.
  • Ability to build strong relationships with internal and external customers and colleagues from varied backgrounds and areas of expertise.
  • Ability to manage multiple projects and priorities simultaneously in a fast-paced, highly matrixed environment and deliver on time.
  • High proficiency in Microsoft Office software.
  • Excellent written and verbal German and English skills.
  • Strong communication, presentation, training, and interpersonal skills.
  • Residence in the assigned territory is mandatory.

Responsibilities

  • Support the development of regional access strategies and drive implementation of the local key account plan for all products and indications, for inpatient and outpatient care, in cooperation with the Director Regional Market Access Germany and cross-functionally with Sales, Marketing, Medical, and Patient Advocacy.
  • Lead operational execution of the Market Access strategy for the assigned region.
  • Build and maintain relationships with regional stakeholders, health care organizations, and drug evaluation committees to ensure patient access to products.
  • Establish working relationships in hospitals with hospital pharmacists or related buying groups, hospital controlling departments, the regional association of statutory health insurance physicians, top account retail pharmacists, and other regional decision-makers to reduce funding barriers.
  • Stay up to date regarding the external market access environment.
  • Organize and manage events with customer groups in collaboration with regional teams.
  • Plan, manage, and monitor defined projects, including processing contracts and agreements with sick funds in alignment with Finance, Legal, and Customer Service.
  • Provide training and information on relevant policies and regulations to sales teams and external customers.
  • Participate in developing regional account plans with other field-based Sales and Medical teams under the Area Manager’s coordination.
  • Maintain a field presence, interact with field staff, and gather and share relevant information to develop and implement action plans.
  • Assess needs with cross-functional brand teams and develop materials and messages to help field teams resolve budget and funding issues in hospital and retail accounts.
  • Organize commercial meetings, access-related round-table meetings in hospitals and outpatient care settings, and similar events.
  • Train sales teams on relevant topics and act as a speaker at regional events.
  • Perform and deliver against key performance indicators.

Desired Qualifications

  • Prior experience with contracting or tendering is a plus.
  • Experience in the rare disease and/or orphan disease market is preferred.
  • Experience launching products in new therapeutic areas is preferable.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs